Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » KineMed

KineMed

Jan 04, 2016

KineMed Collaborates With Pfizer on Proteomics Biomarkers

Building on the companies' existing relationship, the deal licenses KineMed's proteomics platform to the pharmaceuticals giant for CDx development.

Jun 02, 2015

KineMed, Pronutria Ink R&D Collaboration

The partners will use KineMed's proteomics platform to evaluate the effect of biologics developed by Pronutria for metabolic and other diseases.

Jun 06, 2014

In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income.

Jun 06, 2014

KineMed, Pfizer Renew Metabolic Disease Research Collaboration

Premium

NEW YORK (GenomeWeb News) – KineMed this week announced the renewal of its non-exclusive research collaboration with Pfizer into metabolic disease, and type 2 diabetes in particular.

May 23, 2014

KineMed and CHDI Foundation Extend Collaboration on Huntington's Disease Biomarkers

Premium

NEW YORK (GenomeWeb News) – KineMed said this week that it has extended its collaboration with the CHDI Foundation on research into biomarkers for Huntington's disease.

May 23, 2014

People in the News: Patrick Doyle, Dominique Grau, Jean Halloran

Premium

KineMed has tapped Patrick Doyle to be executive VP and chief business officer. In the post, he will head corporate development activities, including licensing and strategic partnerships.

May 19, 2014

KineMed, CHDI Foundation Extend Huntington's Disease Collaboration

NEW YORK (GenomeWeb) – KineMed and CHDI Foundation today said they are extending their collaboration to characterize and track the pathogenesis of Huntington's disease and to evaluate possible therapeutic interventions.

Oct 15, 2013

KineMed Inks Deal with Amgen to Study Brain Proteins Linked to Neurodegenerative Disease

NEW YORK (GenomeWeb News) – KineMed said today that it has entered an agreement with Amgen to apply its mass spec-based Dynamic Proteomics platform to the study of brain protein homeostasis in neurodegenerative disease.

Sep 19, 2013

KineMed Wins $225K SBIR Contract to Develop Myocardial Fibrosis Biomarkers

NEW YORK (GenomeWeb News) – KineMed said today that it has received a $225,000 Phase I Small Business Innovation Research contract from the National Heart, Lung, and Blood Institute for research into biomarkers for the early detection of myocardial fibrosis.

Aug 23, 2013

People in the News: Thomas Bachmann, Joseph Eggler, and More

Premium

Bruker has appointed Thomas Bachmann to be president of its Bruker BioSpin Group.

Pages

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.